The Daily cover image

Why One Drug Company Held Back a Better Drug

The Daily

00:00

The Controversy of Withheld Innovations in Drug Development

This chapter examines the ethical implications of a pharmaceutical company's decision to withhold a safer medication in the pursuit of profit. It highlights internal documents that reveal the executives' thought processes related to FDA approval and the development of a potentially improved drug.

Transcript
Play full episode

The AI-powered Podcast Player

Save insights by tapping your headphones, chat with episodes, discover the best highlights - and more!
App store bannerPlay store banner
Get the app